A NOVEL ANTAGONIST OF THE IMMUNE CHECKPOINT PROTEIN ADENOSINE A2A RECEPTOR RESTORES TUMOR-INFILTRATING LYMPHOCYTE ACTIVITY IN THE CONTEXT OF THE TUMOR MICROENVIRONMENT

A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment

BACKGROUND: Therapeutic strategies targeting immune Jewelry Holders checkpoint proteins have led to significant responses in patients with various tumor types.The success of these studies has led to the development of various antibodies/inhibitors for the different checkpoint proteins involved in immune evasion of the tumor.Adenosine present in hig

read more



Rapidly progressive neovascular glaucoma following coronary artery bypass graft surgery in a patient with type 1 diabetes mellitus: a case report

Abstract Background Proliferative diabetic retinopathy leading to vitreous hemorrhage, tractional retinal detachment, and neovascular glaucoma is a major cause of severe sight impairment in adults of working age worldwide.Neovascular glaucoma occurs in 2.5% of patients with proliferative diabetic retinopathy, which is difficult to treat and often l

read more